Explore our insights

Insights2019-11-21T11:54:02+01:00

INVESTIERE – “I’m bullish about the Swiss startup ecosystem”

July 9th, 2020|Featured, News|

Lucian Wagner has two decades of experience as a startup investor. Together with Jacqueline Ruedin Rüsch, he runs Privilège Ventures, a seed and early-stage venture capital firm active in Switzerland and Europe. In this interview, they share the story of how they came to invest in startups and what fascinates them about the Swiss startup ecosystem.

2705, 2020

Swiss start-ups drive research around Covid-19

May 27th, 2020|Creoptix, Featured|

Swiss start-ups are very active in the quest for therapies against Covid-19. You can find several examples in our article from 5 May. According to the weekly updated view of the Covid-19 product pipeline creates by BIO’a Industry Analysis Team, Swiss companies run 25 different therapeutic programmes - more than companies from UK (22), Germany (21) or France (12).

704, 2020

ScanTrust Case Study: Dealing with Counterfeit Seed Products & Establishing Loyalty

April 7th, 2020|ScanTrust|

When the sale of imitation and counterfeit seeds became a problem for our client, a Fortune Global 500 company and a major developer of patented seed products, they needed a quick and effective solution.

2603, 2020

Utility of AVA – the Ava Bracelet to Diagnose and Monitor Symptoms Potentially Related to COVID-19

March 26th, 2020|Ava|

The Ava Bracelet is a wrist worn medical device* that tracks breathing rate, pulse rate, skin temperature, heart rate variability and perfusion. The most common symptoms of COVID-19 include fever (87.9% of cases), dry cough (67.7% of cases), and shortness of breath (18.6% of cases).

Ready to talk?

If you wish to get in touch just go ahead.

Let’s Talk
Go to Top